文献速递胃肠外科围术期管理与 ERAS

局部晚期直肠癌新辅助放化疗反应不佳者延迟手术与肿瘤长期结局的关联

Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation.
PubMed 文献 · JAMA Surg · 2021-01-01

这项多中心回顾性队列研究分析了2000至2014年间12家意大利转诊中心的1701例直肠癌患者,筛选出对术前放化疗反应轻微或无反应的1064例。按新辅助治疗结束至手术等待时间分为短等待组(≤8周,579例)和长等待组(>8周,485例)。长等待组5年和10年总生存率及无病生存率均显著更差,多因素分析显示长等待时间与死亡和死亡/复发风险增加独立相关。

要点

  • 对放化疗反应不佳的局部晚期直肠癌,手术等待>8周与更差的总生存和无病生存相关。
  • 长等待组5年总生存67.6% vs 短等待组80.3%,10年40.1% vs 57.8%。
  • 长等待组死亡风险增加(HR 1.84),死亡/复发风险增加(HR 1.69)。

核心结论

  • 对新辅助放化疗反应不佳的直肠癌,完成放化疗后较长等待间隔与更差的总生存和无病生存相关。
  • 基于此,对放化疗反应不佳的患者应早期识别并尽快手术,避免延迟。

研究设计与样本

  • 多中心回顾性队列研究,纳入12家意大利转诊中心2000年1月至2014年12月间连续收治的1701例直肠癌手术患者。
  • 筛选对术前放化疗反应轻微或无反应(ypT2-3或ypN阳性)的患者共1064例,按等待时间≤8周(579例)和>8周(485例)分组比较。

主要发现

  • 长等待组5年总生存率67.6%(95%CI 63.1%-71.7%)vs 短等待组80.3%(95%CI 76.5%-83.6%),10年40.1%(95%CI 33.5%-46.5%)vs 57.8%(95%CI 52.1%-63.0%),P<.001。
  • 长等待组5年无病生存率59.6%(95%CI 54.9%-63.9%)vs 72.0%(95%CI 67.9%-75.7%),10年36.2%(95%CI 29.9%-42.4%)vs 53.9%(95%CI 48.5%-59.1%),P<.001。
  • 多因素分析中,长等待时间与死亡风险增加相关(HR 1.84;95%CI 1.50-2.26;P<.001),与死亡/复发风险增加相关(HR 1.69;95%CI 1.39-2.04;P<.001)。

临床怎么用

  • 对局部晚期直肠癌新辅助放化疗后反应不佳者,应在放化疗结束后早期识别,并尽快安排手术,避免不必要的延迟。
  • 等待时间决策需权衡肿瘤反应,对反应差者倾向于缩短等待间隔。

局限性

  • 回顾性队列设计可能存在选择偏倚和混杂因素。
  • 仅纳入意大利12家转诊中心患者,外推性需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Extending the interval between the end of neoadjuvant chemoradiotherapy (CRT) and surgery may enhance tumor response in patients with locally advanced rectal cancer. However, data on the association of delaying surgery with long-term outcome in patients who had a minor or poor response are lacking. OBJECTIVE: To assess a large series of patients who had minor or no tumor response to CRT and the association of shorter or longer waiting times between CRT and surgery with short- and long-term outcomes. DESIGN, SETTING, AND PARTICIPANTS: This is a multicenter retrospective cohort study. Data from 1701 consecutive patients with rectal cancer treated in 12 Italian referral centers were analyzed for colorectal surgery between January 2000 and December 2014. Patients with a minor or null tumor response (ypT stage of 2 to 3 or ypN positive) stage greater than 0 to neoadjuvant CRT were selected for the study. The data were analyzed between March and July 2020. EXPOSURES: Patients who had a minor or null tumor response were divided into 2 groups according to the wait time between neoadjuvant therapy end and surgery. Differences in surgical and oncological outcomes between these 2 groups were explored. MAIN OUTCOMES AND MEASURES: The primary outcomes were overall and disease-free survival between the 2 groups. RESULTS: Of a total of 1064 patients, 654 (61.5%) were male, and the median (IQR) age was 64 (55-71) years. A total of 579 patients (54.4%) had a shorter wait time (8 weeks or less) 485 patients (45.6%) had a longer wait time (greater than 8 weeks). A longer waiting time before surgery was associated with worse 5- and 10-year overall survival rates (67.6% [95% CI, 63.1%-71.7%] vs 80.3% [95% CI, 76.5%-83.6%] at 5 years; 40.1% [95% CI, 33.5%-46.5%] vs 57.8% [95% CI, 52.1%-63.0%] at 10 years; P < .001). Also, delayed surgery was associated with worse 5- and 10-year disease-free survival (59.6% [95% CI, 54.9%-63.9%] vs 72.0% [95% CI, 67.9%-75.7%] at 5 years; 36.2% [95% CI, 29.9%-42.4%] vs 53.9% [95% CI, 48.5%-59.1%] at 10 years; P < .001). At multivariate analysis, a longer waiting time was associated with an augmented risk of death (hazard ratio, 1.84; 95% CI, 1.50-2.26; P < .001) and death/recurrence (hazard ratio, 1.69; 95% CI, 1.39-2.04; P < .001). CONCLUSIONS AND RELEVANCE: In this cohort study, a longer interval before surgery after completing neoadjuvant CRT was associated with worse overall and disease-free survival in tumors with a poor pathological response to preoperative CRT. Based on these findings, patients who do not respond well to CRT should be identified early after the end of CRT and undergo surgery without delay.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Deidda S, Elmore U, Rosati R, et al. Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation. JAMA Surg. 2021. PMID: 34586340. doi:10.1001/jamasurg.2021.4566

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。